Search results
Pfizer wants the $75 mln left from SAC Capital’s insider trading settlement with SEC
Reuters· 17 hours agoPharma company Pfizer told a New York federal judge on Monday that it is entitled to recoup about...
Pfizer First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 1 day agoPfizer (NYSE:PFE) First Quarter 2024 Results Key Financial Results Revenue: US$14.9b (down 19% from...
Patient dies in Pfizer study of Duchenne gene therapy
BioPharma Dive via Yahoo Finance· 21 hours agoPfizer said the patient, a young boy who was treated earlier last year, had died suddenly from...
Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend
Simply Wall St. via Yahoo Finance· 4 days agoReaders hoping to buy Pfizer Inc. (NYSE:PFE) for its dividend will need to make their move shortly,...
AstraZeneca: What are the rare side effects of the Covid jab?
The Independent via Yahoo News· 3 hours agoAround 50 million doses of the the Oxford-AstraZeneca were administered in the UK by autumn 2021....
AstraZeneca pulls Covid vaccine after admitting rare side effect
Daily Express· 14 hours agoThe Oxford-AstraZeneca Covid vaccine is set to be withdrawn after the pharmaceutical giant admitted...
Leerink Partnrs Comments on Pfizer Inc.’s Q2 2024 Earnings (NYSE:PFE)
ETF DAILY NEWS· 1 day agoPfizer Inc. (NYSE:PFE – Free Report) – Stock analysts at Leerink Partnrs upped their Q2 2024 earnings estimates for Pfizer in a report issued on Thursday ...
European Medicines Agency pulls authorization for AstraZeneca's COVID shot, at company's request
WSLS Newschannel 10 Roanoke· 2 hours agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
AstraZeneca removes Covid vaccine after very rare side effect linked to deaths
The US Sun· 2 hours agoIt is another sign that the outbreak is consigned to history after the World Health Organisation...
Pfizer Is Adding a Wall Street Analyst to Its C-Suite. What He Thinks the Company Needs to Do.
Barrons.com· 2 days agoSTOCK ALERT Andrew Baum, the prominent Wall Street drug company analyst, has never been much of a...